Literature DB >> 16574908

Impact of TASK-1 in human pulmonary artery smooth muscle cells.

Andrea Olschewski1, Yingji Li, Bi Tang, Jörg Hanze, Bastian Eul, Rainer M Bohle, Jochen Wilhelm, Rory E Morty, Michael E Brau, E Kenneth Weir, Grazyna Kwapiszewska, Walter Klepetko, Werner Seeger, Horst Olschewski.   

Abstract

The excitability of pulmonary artery smooth muscle cells (PASMC) is regulated by potassium (K+) conductances. Although studies suggest that background K+ currents carried by 2-pore domain K+ channels are important regulators of resting membrane potential in PASMC, their role in human PASMC is unknown. Our study tested the hypothesis that TASK-1 leak K+ channels contribute to the K+ current and resting membrane potential in human PASMC. We used the whole-cell patch-clamp technique and TASK-1 small interfering RNA (siRNA). Noninactivating K+ current performed by TASK-1 K+ channels were identified by current characteristics and inhibition by anandamide and acidosis (pH 6.3), each resulting in significant membrane depolarization. Moreover, we showed that TASK-1 is blocked by moderate hypoxia and activated by treprostinil at clinically relevant concentrations. This is mediated via protein kinase A (PKA)-dependent phosphorylation of TASK-1. To further confirm the role of TASK-1 channels in regulation of resting membrane potential, we knocked down TASK-1 expression using TASK-1 siRNA. The knockdown of TASK-1 was reflected by a significant depolarization of resting membrane potential. Treatment of human PASMC with TASK-1 siRNA resulted in loss of sensitivity to anandamide, acidosis, alkalosis, hypoxia, and treprostinil. These results suggest that (1) TASK-1 is expressed in human PASMC; (2) TASK-1 is hypoxia-sensitive and controls the resting membrane potential, thus implicating an important role for TASK-1 K+ channels in the regulation of pulmonary vascular tone; and (3) treprostinil activates TASK-1 at clinically relevant concentrations via PKA, which might represent an important mechanism underlying the vasorelaxing properties of prostanoids and their beneficial effect in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574908     DOI: 10.1161/01.RES.0000219677.12988.e9

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  84 in total

1.  TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation.

Authors:  C Seyler; E Duthil-Straub; E Zitron; J Gierten; E P Scholz; R H A Fink; C A Karle; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Breathing Stimulant Compounds Inhibit TASK-3 Potassium Channel Function Likely by Binding at a Common Site in the Channel Pore.

Authors:  Rikki H Chokshi; Aaron T Larsen; Brijesh Bhayana; Joseph F Cotten
Journal:  Mol Pharmacol       Date:  2015-08-12       Impact factor: 4.436

Review 3.  Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?

Authors:  Michel Félétou
Journal:  Br J Pharmacol       Date:  2009-01-29       Impact factor: 8.739

4.  Intracellular traffic of the K+ channels TASK-1 and TASK-3: role of N- and C-terminal sorting signals and interaction with 14-3-3 proteins.

Authors:  Marylou Zuzarte; Katja Heusser; Vijay Renigunta; Günter Schlichthörl; Susanne Rinné; Erhard Wischmeyer; Jürgen Daut; Blanche Schwappach; Regina Preisig-Müller
Journal:  J Physiol       Date:  2009-01-12       Impact factor: 5.182

Review 5.  Two-pore potassium channels in the cardiovascular system.

Authors:  Alison Gurney; Boris Manoury
Journal:  Eur Biophys J       Date:  2008-05-01       Impact factor: 1.733

Review 6.  Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.

Authors:  M Borsotto; J Veyssiere; H Moha Ou Maati; C Devader; J Mazella; C Heurteaux
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

7.  TASK-1 Potassium Channels Limit Pancreatic α-Cell Calcium Influx and Glucagon Secretion.

Authors:  Prasanna K Dadi; Brooke Luo; Nicholas C Vierra; David A Jacobson
Journal:  Mol Endocrinol       Date:  2015-04-07

Review 8.  Much more than a leak: structure and function of K₂p-channels.

Authors:  Vijay Renigunta; Günter Schlichthörl; Jürgen Daut
Journal:  Pflugers Arch       Date:  2015-03-21       Impact factor: 3.657

9.  Pancreatic β-cell-specific ablation of TASK-1 channels augments glucose-stimulated calcium entry and insulin secretion, improving glucose tolerance.

Authors:  Prasanna K Dadi; Nicholas C Vierra; David A Jacobson
Journal:  Endocrinology       Date:  2014-06-16       Impact factor: 4.736

Review 10.  Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact.

Authors:  Douglas A Bayliss; Paula Q Barrett
Journal:  Trends Pharmacol Sci       Date:  2008-09-25       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.